Asia Times - February 25, 2003
The new product can give a result within 30 minutes while requiring no additional facilities, compared with conventional testing methods that take at least two weeks, according to scientists at Xiamen University and the Beijing Wantai Biological Pharmacy Enterprise, which jointly developed the product.
It is convenient for emergency tests in hospitals and blood-donation centers in remote areas, and could be used by individuals, said Jiang Yan, a researcher with an HIV/AIDS center under the Chinese Center for Disease Control and Prevention.
At least a million people in China are estimated to be infected by HIV, most of whom are unaware of their situation, partly due to the lack of a testing service. Only 9,824 people nationwide were confirmed through tests as being HIV-positive last year, the Ministry of Health (MOH) said.
A card-like device with the reagent tells whether a person is HIV-positive by showing purplish lines when touched with drops of sample blood. A single line on the card indicates HIV-negative, while two lines mean that the person is HIV-positive.
While the new device is as accurate as other Chinese-made HIV test reagents, which are also on a par with foreign products, it is much less expensive because it is completely produced from domestic materials, said Wang Youchun, director of the Cell Lab of the Beijing Research Institute of Biological Products.
As a result of better efficiency in HIV tests, China no longer solely depends on imported products, which will benefit the diagnosis and prevention of the deadly disease nationwide, Wang said.
As well as diagnosis and prevention, China will boost treatment services since an increasing number of HIV carriers are developing into AIDS patients, according to the MOH. Experts estimate that between 80,000 and 100,000 patients are awaiting treatment across China at present.
The MOH has chosen 51 counties in HIV-plagued provinces to carry out a program of medical treatment and care, health education and behavioral intervention among people living with HIV/AIDS. The program will be introduced to more areas in the next two years.
030225
AT030209
Copyright © 2003 - Asia Times Online. Reproduction of this article (other than one copy for personal reference) must be cleared through Asia Times Online, 6306 The Center, Queen’s Road, Central, Hong Kong.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .